Back
Sarepta Therapeutics Vs. GeneDx Holdings Corp - Ordinary Shares - Class A Industry Stock Comparison
Buy
70
SRPT
Sarepta Therapeutics
Last Price:
$21.81
Seasonality Move:
8.12%
Buy
89
WGS
GeneDx Holdings Corp - Ordinary Shares - Class A
Last Price:
$126.30
Seasonality Move:
-11.2%
Buy
70
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $21.81. The Score for SRPT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
89
GeneDx Holdings Corp - Ordinary Shares - Class A (WGS)
is a Buy
Is GeneDx Holdings Corp - Ordinary Shares - Class A a Buy, Sell or Hold?
-
The current GeneDx Holdings Corp - Ordinary Shares - Class A [WGS] share price is $126.36. The Score for WGS is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
-
WGS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $21.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
WGS Stock Price Chart
What is GeneDx Holdings Corp - Ordinary Shares - Class A's stock price today?
-
The GeneDx Holdings Corp - Ordinary Shares - Class A share price today is $126.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.03 | Buy |
Relative Strength Index (14 RSI): | 61.42 | Buy |
Chaikin Money Flow: | 6597638 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.11 - 19.59) | Buy |
Bollinger Bands (100): | (17.55 - 53.77) | Sell |
WGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 29.99 | Buy |
Relative Strength Index (14 RSI): | 80.64 | Buy |
Chaikin Money Flow: | 569974 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.12 - 112.58) | Buy |
Bollinger Bands (100): | (67.88 - 101.4) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.96 | Buy |
20-day SMA: | 16.47 | Buy |
50-day SMA: | 20.62 | Buy |
200-day SMA: | 75.35 | Sell |
8-day EMA: | 18.91 | Buy |
20-day EMA: | 13.99 | Buy |
50-day EMA: | 7.79 | Buy |
200-day EMA: | 2.35 | Buy |
WGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 114.53 | Buy |
20-day SMA: | 100.92 | Buy |
50-day SMA: | 88.09 | Buy |
200-day SMA: | 82.76 | Buy |
8-day EMA: | 113.78 | Buy |
20-day EMA: | 84.98 | Buy |
50-day EMA: | 47.46 | Buy |
200-day EMA: | 14.32 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $1.27 per share, a decrease this year of $5.65 per share, and an increase next year of $5.32 per share.
GeneDx Holdings Corp - Ordinary Shares - Class A Earnings Growth & WGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.18 per share, an increase this year of $2.09 per share, and an increase next year of $0.62 per share.
Sarepta Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GeneDx Holdings Corp - Ordinary Shares - Class A Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |